Measurement-Based Peer Supervision App for Non-Specialist Providers
Launched by DIMAGI INC. · Jul 15, 2025
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new digital app designed to help community health workers and other non-specialist providers improve their skills in counseling people with anxiety or depression. The app aims to make these providers feel more confident and supported as they deliver therapy, and the study will explore how the app can best assist them in their work.
People who are 18 years or older, speak English, and have already completed a specific training called EMPOWER Behavioral Activation may be eligible to join. Participants will take part in virtual meetings and use the app as part of their ongoing work in counseling. This study is currently recruiting volunteers and is open to all genders. If you’re someone who fits these criteria and is interested in helping improve mental health support in your community, this trial might be a good fit.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older;
- • English-speaking; and
- • Completed EMPOWER Behavioral Activation training
- Exclusion Criteria:
- • - Unable to participate in virtual meetings
About Dimagi Inc.
Dimagi Inc. is a pioneering social enterprise dedicated to improving healthcare delivery through innovative technology solutions. With a focus on using open-source software and mobile applications, Dimagi empowers frontline workers and healthcare providers in low-resource settings to enhance patient care and data management. The organization is committed to advancing health outcomes through collaborative partnerships, leveraging its expertise in digital health to facilitate scalable and sustainable interventions. By bridging the gap between technology and healthcare, Dimagi aims to transform the way health services are delivered, monitored, and evaluated globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Yun Xian Ho, PhD
Principal Investigator
Dimagi Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported